PsyBio Therapeutics Reports First Quarter 2021 Financial Results, Provides Shareholder Update and Announces Intention to… Jun 1, 2021
Cybin Announces Sponsorship of a Kernel Flow Feasibility Study to Measure Ketamine’s Psychedelic Effects on Cerebral… Jun 1, 2021
National Institutes of Health Director Praises Psychedelics and Medical Cannabis Research May 31, 2021
